Evidence map›Paper›PMID 32575816›Full record

ArticleJournal of clinical medicine2020

Impulsivity, Emotional Dysregulation and Executive Function Deficits Could Be Associated with Alcohol and Drug Abuse in Eating Disorders.

María Lozano-Madrid, Danielle Clark Bryan, Roser Granero, Isabel Sánchez, Nadine Riesco, Núria Mallorquí-Bagué, Susana Jiménez-Murcia, Janet Treasure, Fernando Fernández-Aranda

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Binge eating disorder.Nature reviews. Disease primers · 2022
    Article
  11. Article
  12. Article
  13. Advances in Eating Disorders.Journal of clinical medicine · 2020
    Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

María Lozano-MadridDepartment of Psychiatry, Bellvitge University Hospital-IDIBELL, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0003-3833-317X
Danielle Clark BryanDepartment of Psychological Medicine, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, SE5 8AF London, UK.ORCID 0000-0002-6422-7306
Roser GraneroCiber Fisiopatologia Obesidad y Nutrición (CIBERobn), Instituto Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0001-6308-3198
Isabel SánchezDepartment of Psychiatry, Bellvitge University Hospital-IDIBELL, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Nadine RiescoDepartment of Psychiatry, Bellvitge University Hospital-IDIBELL, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-6336-4907
Núria Mallorquí-BaguéCiber Fisiopatologia Obesidad y Nutrición (CIBERobn), Instituto Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-1434-3162
Susana Jiménez-MurciaDepartment of Psychiatry, Bellvitge University Hospital-IDIBELL, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Janet TreasureDepartment of Psychological Medicine, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, SE5 8AF London, UK.
Fernando Fernández-ArandaDepartment of Psychiatry, Bellvitge University Hospital-IDIBELL, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-2968-9898
Instituto de Salud Carlos III · ESKing's College London · GBUniversitat Autònoma de Barcelona · ES

Funding

CERCA Program/Generalitat de Catalunya NACIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) NAFEDER funds/European Regional Development Fund (ERDF) NAInstitute of Psychiatry, King's College London NAInstituto de Salud Carlos III (ISCIII) FIS PI17/01167Maudsley NHS Foundation Trust NAMinisterio de Educación, Cultura y Deporte, Spain FPU15/02911National Institute for Health Research (NIHR) NASpecialist Biomedical Research Centre for Mental Health award to the South London NA
6 · The paper itself

Abstract

backgroundEmpirical data suggests a high comorbid occurrence of eating disorders (EDs) and substance use disorders (SUDs), as well as neurological and psychological shared characteristics. However, no prior study has identified the neuropsychological features of this subgroup. This study examines the prevalence of alcohol and/or drug abuse (A/DA) symptoms in ED patients. It also compares the clinical features and neuropsychological performance of ED patients with and without A/DA symptoms.

methods145 participants (74.5% females) with various forms of diagnosed EDs underwent a comprehensive clinical (TCI-R, SCL-90-R and EDI-2) and neuropsychological assessment (Stroop, WCST and IGT).

resultsApproximately 19% of ED patients (across ED subtypes) had A/DA symptoms. Those with A/DA symptoms showed more impulsive behaviours and higher levels of interoceptive awareness (EDI-2), somatisation (SCL-90-R) and novelty seeking (TCI-R). This group also had a lower score in the Stroop-words measure, made more perseverative errors in the WCST and showed a weaker learning trajectory in the IGT.

conclusionsED patients with A/DA symptoms display a specific phenotype characterised by greater impulsive personality, emotional dysregulation and problems with executive control. Patients with these temperamental traits may be at high risk of developing a SUD.

Indexed as

alcohol and/or drug abuseeating disorderemotional dysregulationexecutive functionsimpulsivitysubstance use disorder

Identifiers

PMID32575816
PMCPMC7355820
OpenAlexW3036558342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.